Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
Lifecore Biomedical is a contract development and manufacturing organization (CDMO) that partners with customers to develop and manufacture pharmaceuticals, including a focus on supplying the ophthalmics industry. It provides quality, development, and manufacturing services to pharmaceutical and biomedical companies.
0 investors
Lanier Biotherapeutics is a biotherapeutics company. The page provides no specific detail about its products, pipeline, or target market.
0 investors
0 investors
LAPIX Therapeutics is a clinical-stage biopharmaceutical company developing an orally administered, non-immunosuppressive T-cell engager therapy for people with autoimmune diseases. Its lead therapeutic, LPX-TI641, is an antigen-agnostic TIM pathway agonist targeting TIM-3 and TIM-4 receptors to restore immune balance across a range of autoimmune conditions.
0 investors
Larimar Therapeutics is a clinical-stage biotechnology company developing nomlabofusp, a subcutaneously administered protein designed to deliver an essential protein to mitochondria in patients with Friedreich's ataxia, a rare genetic disease characterized by severe protein deficiency. The company leverages proprietary cell-penetrating peptide technology to enable delivery of therapeutic molecules across cell membranes for treating rare intracellular disorders.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Laxco is a supplier of laboratory and scientific instruments, including life science and digital imaging products. It serves laboratory and research markets.
0 investors
Laxmi Therapeutic Devices develops wearable diabetes management technology to improve patient health outcomes and time in range.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Lennham applies deuterium chemistry to modify the metabolic and pharmacokinetic properties of drug compounds, aiming to develop pharmaceutical products with improved profiles and patent protection. The company identifies compounds that could benefit from such modification and advances candidates with clinical and commercial potential.
0 investors
0 investors
0 investors
0 investors
LevEllis develops PROVOQUE, a topical facial serum built on the complete skin-specific secretome (growth factors, exosomes, and fetuin-A) sourced from skin progenitor cells. The company operates in regenerative aesthetics and skincare, offering a science-based product for aesthetic medicine and skin health.
0 investors
0 investors